You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 135 No. 1, January 1975 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  SYMPOSIUM ON MYELOMA
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (175)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

IgD Multiple Myeloma

Review of 133 Cases

Zygmunt Jancelewicz, MD, FRCP(C); Kiyoshi Takatsuki, MD; Susumi Sugai, MD; Waldemar Pruzanski, MD, FRCP(C), FACP

Arch Intern Med. 1975;135(1):87-93.


Abstract



One hundred thirty-three patients had IgD myeloma. The IgD comprises 0.8% of M-components in general and 2.1% of myelomas in particular. Males predominate and 65% of the patients are younger than 60 years at the diagnosis. More than half of the patients have lymphadenopathy, hepatomegaly, or splenomegaly. Extraosseous spread and amyloidosis are frequent. Severe anemia and azotemia are common. Total serum protein and IgD M-component levels are usually not high. {lambda}-Type light chains are found in 90% of IgD M-components. Bence Jones proteinemia is frequent and Bence Jones proteinuria appears in almost all patients. Mean survival is 13.7 months from diagnosis. The IgD is different from IgG and IgA myeloma, indicating that the clinical picture and course of multiple myeloma may be related to the class and type of M-component.



Author Affiliations



From the Immunoglobulin Diagnostic and Research Centre of the University of Toronto, the Wellesley Hospital, Toronto (Drs. Jancelewicz and Pruzanski), and the Department of Medicine, Kyoto University, Kyoto, Japan (Drs. Takatsuki and Sugai).


Footnotes



Received for publication March 7, 1974; accepted May 16.

Reprint requests to the Wellesley Hospital, Toronto, Ontario M4Y, 1J3, Canada (Dr. Pruzanski).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Immunoglobulin D amyloidosis: a distinct entity
Gertz et al.
Blood 2012;119:44-48.
ABSTRACT | FULL TEXT  

Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients
Kim et al.
Ann Oncol 2011;22:411-416.
ABSTRACT | FULL TEXT  

Efficacy and outcome of autologous transplantation in rare myelomas
Morris et al.
haematol 2010;95:2126-2133.
ABSTRACT | FULL TEXT  

A Healthy Young Man Presenting with Multiple Rib Fractures
Harle et al.
Clin. Chem. 2010;56:1390-1392.
FULL TEXT  

Cutaneous Involvement in Multiple Myeloma: A Clinicopathologic, Immunohistochemical, and Cytogenetic Study of 8 Cases
Requena et al.
Arch Dermatol 2003;139:475-486.
ABSTRACT | FULL TEXT  

Immunoglobulin D: Properties, Measurement, and Clinical Relevance
Vladutiu
CVI 2000;7:131-140.
FULL TEXT  

Immunoperoxidase Characterization of a Pharyngeal Plasmacytoma
Humphrey et al.
Arch Otolaryngol Head Neck Surg 1982;108:362-365.
ABSTRACT  

Plasma Cell Neoplasia With Osteosclerotic Lesions: A Study of Five Cases and a Review of the Literature
Driedger and Pruzanski
Arch Intern Med 1979;139:892-896.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.